Global Down Syndrome Foundation, the National Down Syndrome Congress, and the National Down Syndrome Society Highlight the FDA’s Public Warning About Risks Associated with Non-Invasive Prenatal Screening Tests Atlanta, Denver, New York, April 27, 2022 (GLOBE NEWSWIRE) -- Last week, the U.S. Food and Drug Administration (FDA) warned the public of the risk of false results, inappropriate use, and...